Cyclacel Pharmaceuticals Inc (STU:UXI)
€ 0.55 0 (0%) Market Cap: 1.96 Mil Enterprise Value: -898,000.00 PE Ratio: 0 PB Ratio: 0 GF Score: 33/100

Cyclacel Pharmaceuticals Inc at Ladenburg Thalmann Virtual Healthcare Conference Transcript

Jul 14, 2021 / 02:30PM GMT
Release Date Price: €68.85 (-1.82%)
Ahu Demir
Ladenburg Thalmann & Co. Inc. - Analyst

Hello, everyone. Our next presenting company is Cyclacel Pharmaceuticals. And from the Company we have CEO, Spiro Rombotis. Spiro, thank you so much for joining us today, and it's our great pleasure to host Cyclacel presentation. I'll pass it to you for a presentation, then following up -- I'll follow-up with a Q&A session. Please take it away.

Spiro Rombotis
Cyclacel Pharmaceuticals, Inc. - President & CEO

Thank you, Ahu, and thank you very much to Ladenburg for inviting us to join this year's healthcare conference. I would also like to introduce my colleague, Paul McBarron, our COO and CFO, who joins me today. I will go through a few slides just primarily to remind everybody of our endeavors to bring solutions to patients with unmet medical needs, and then will turn into questions.

First of all, I would like to draw your attention to our usual disclaimer regarding forward-looking statements I'll be making in my presentation and my subsequent remarks, and direct your attention to our

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot